Paradoxical gastrointestinal effects of interleukin-17 blockers
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-218719
Abstract: We read with great interest the review written by Fauny et al 1 which describes the relevance of interleukin-23/T-helper 17 (IL-23/Th17) pathway in inflammatory bowel disease (IBD). However, drugs targeting IL-17 have shown the opposite… read more here.
Keywords: gastrointestinal effects; paradoxical gastrointestinal; effects interleukin; interleukin blockers ... See more keywords